MATAWAN, N.J.--(BUSINESS WIRE)--Feb. 3, 2004--iVoice, Inc. (OTC Bulletin Board: IVOC - News), a leader in speech recognition technology, announced today it has filed an additional patent application with the U.S. Patent and Trademark Office. The application is titled: Methodology for Talking Prescription Bottle With Voice Instructions via Wireless Technology.
Approximately three billion prescriptions are filled each year with the number of prescriptions expected to climb to four billion in 2004. Pharmacies have been struggling with the issue of label readability and comprehension for many years. With the iVoice patent pending technology, prescription bottles will tell users what medication is inside and the proper dosage, along with any other important directions and warnings.

The present inventions include methods of communicating prescription instructions to the patient's medicine or prescription bottle. The methodology involves providing a medicine or prescription container with dosage instructions and warnings for the medication, via wireless technology. Optional software permits simultaneous labeling and wireless wav file transmission to make the medicine container a speaking product that is compliant with law.

iVoice's commitment to innovative technology continues to help customers meet their client requirements. We believe that our intellectual property and our technology provide iVoice with a superior suite of application offerings designed for the Speech Recognition industry.

About iVoice, Inc.

iVoice, Inc. designs, manufactures and markets innovative voice and computer telephony communications systems for businesses and corporate departments. Its speech-enabled communication systems and software are designed to be cost effective solutions that improve a users calling experience by streamlining the call handling process through speech recognition technology. iVoice has demonstrated and met interoperability standards for many of the world's top telephony equipment manufacturers'.

NOTE: Any statements that are not historical facts contained in this release are forward-looking statements. It is possible that the assumptions made by management for purposes of such statements may not materialize. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements may involve risks and uncertainties, including but not limited to those relating to product demand, pricing, market acceptance, the effect of economic conditions, and intellectual property rights, and the outcome of competitive products, risks in product development, the results of financing effort, the ability to complete transactions, and other risks identified in this release, and the Company's Securities and Exchange Commission filings.

--------------------------------------------------------------------------------
Contact:
iVoice, Inc.
Investor Relations:
Dolores Serafin
1-732-441-7700 and say "Investor Relations"
investors@ivoice.com
www.ivoice.com